Company Filing History:
Years Active: 1999
Title: Galina Borisova: Innovator in Hepatitis B Research
Introduction
Galina Borisova is a distinguished inventor based in Riga, Latvia. She has made significant contributions to the field of immunology, particularly in the development of innovative therapeutic solutions for hepatitis B.
Latest Patents
Galina holds a patent for the Inhibin-HBc fusion protein. This fusion protein is formed of an antigenic inhibin peptide inserted into the hepatitis B capsid protein. It is expressed from a chimeric gene, forming an effective immunogen that induces anti-inhibin antibodies when administered to a host animal.
Career Highlights
Galina Borisova is affiliated with Michigan State University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on hepatitis B treatment and vaccine development.
Collaborations
Galina has collaborated with notable colleagues, including James J Ireland and Paul Pumpens, enhancing the scope and depth of her research initiatives.
Conclusion
Galina Borisova's innovative work in the field of hepatitis B research exemplifies her commitment to advancing medical science. Her contributions are paving the way for new therapeutic approaches to combat this viral infection.